Meeder Asset Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-42
| Closed | -$1.69K | – | 1057 |
|
|
2024
Q4 | $1.69K | Sell |
42
-1,916
| -98% | -$77.1K | ﹤0.01% | 889 |
|
|
2024
Q3 | $124K | Buy |
1,958
+1,156
| +144% | +$73.2K | 0.01% | 272 |
|
|
2024
Q2 | $42.5K | Buy |
802
+469
| +141% | +$24.9K | ﹤0.01% | 366 |
|
|
2024
Q1 | $27.3K | Buy |
+333
| New | +$27.3K | ﹤0.01% | 441 |
|
|
2020
Q4 | – | Sell |
-9,258
| Closed | -$53K | – | 2243 |
|
|
2020
Q3 | $53K | Buy |
+9,258
| New | +$53K | ﹤0.01% | 950 |
|
|
2019
Q1 | – | Sell |
-7,309
| Closed | -$56K | – | 1873 |
|
|
2018
Q4 | $56K | Buy |
7,309
+2,839
| +64% | +$21.8K | 0.01% | 785 |
|
|
2018
Q3 | $78K | Buy |
4,470
+4,334
| +3,187% | +$75.6K | 0.01% | 692 |
|
|
2018
Q2 | $1.29K | Buy |
+136
| New | +$1.29K | ﹤0.01% | 1461 |
|